Atlas Capital Advisors LLC Teva Pharmaceutical Industries LTD Transaction History

Atlas Capital Advisors LLC

  • $788 Billion
  • Q4 2024

A detailed history of Atlas Capital Advisors LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 41,040 shares of TEVA stock, worth $688,651. This represents 0.11% of its overall portfolio holdings.

Number of Shares
41,040
Previous 43,119 4.82%
Holding current value
$688,651
Previous $777 Million 16.41%
% of portfolio
0.11%
Previous 0.12%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$16.43 - $22.77 $34,157 - $47,338
-2,079 Reduced 4.82%
41,040 $905 Million
Q3 2024

Nov 05, 2024
SELL
$15.81 - $18.96 $12,205 - $14,637
-772 Reduced 1.76%
43,119 $777 Million
Q2 2024

Jul 29, 2024
BUY
$12.78 - $17.4 $1,904 - $2,592
149 Added 0.34%
43,891 $713 Million
Q1 2024

Apr 15, 2024
BUY
$10.67 - $14.43 $453,496 - $613,303
42,502 Added 3427.58%
43,742 $617 Million
Q2 2023

Aug 15, 2023
SELL
$7.2 - $9.47 $148,946 - $195,905
-20,687 Reduced 94.34%
1,240 $9.34 Million
Q3 2022

Nov 08, 2022
BUY
$6.86 - $11.95 $63,455 - $110,537
9,250 Added 72.97%
21,927 $177 Million
Q1 2022

May 11, 2022
BUY
$7.33 - $9.39 $14,564 - $18,657
1,987 Added 18.59%
12,677 $119 Million
Q4 2021

Feb 01, 2022
BUY
$7.9 - $10.19 $21,085 - $27,197
2,669 Added 33.28%
10,690 $85.6 Million
Q1 2021

May 10, 2021
SELL
$10.34 - $12.81 $46,064 - $57,068
-4,455 Reduced 35.71%
8,021 $92,000
Q2 2020

Jul 28, 2020
SELL
$8.12 - $13.12 $5,074 - $8,200
-625 Reduced 4.77%
12,476 $153,000
Q1 2020

May 04, 2020
BUY
$6.69 - $13.45 $87,164 - $175,240
13,029 Added 18095.83%
13,101 $117,000
Q3 2019

Nov 01, 2019
SELL
$6.16 - $9.6 $43,243 - $67,392
-7,020 Reduced 98.98%
72 $0
Q2 2019

Jul 25, 2019
SELL
$8.12 - $15.72 $207,474 - $401,661
-25,551 Reduced 78.27%
7,092 $0
Q1 2019

Apr 29, 2019
SELL
$15.58 - $20.01 $8,724 - $11,205
-560 Reduced 1.69%
32,643 $0
Q4 2018

Jan 29, 2019
BUY
$14.59 - $23.84 $104,158 - $170,193
7,139 Added 27.39%
33,203 $511,000
Q3 2018

Nov 09, 2018
SELL
$21.06 - $25.65 $200,343 - $244,008
-9,513 Reduced 26.74%
26,064 $0
Q2 2018

Jul 30, 2018
SELL
$16.77 - $24.71 $46,469 - $68,471
-2,771 Reduced 7.23%
35,577 $0
Q1 2018

Apr 18, 2018
BUY
$16.68 - $22.07 $639,644 - $846,340
38,348 New
38,348 $0

Others Institutions Holding TEVA

# of Institutions
675
Shares Held
578M
Call Options Held
25.5M
Put Options Held
14.7M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.6B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email